secwatch.observer — SEC 8-K summary
======================================

Issuer:     Panbela Therapeutics, Inc. (—)
CIK:        0001029125
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001437749-23-000652
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Panbela Therapeutics receives Nasdaq delisting notice; bid price below $0.10 for 10 days
--------------------------------------------------------------------------------

- On Jan 3, 2023, Nasdaq notified Panbela that its common stock closed at $0.10 or less for 10 consecutive trading days, triggering delisting.
- Trading suspension scheduled for Jan 12, 2023; company requested hearing by Jan 10, 2023 to stay delisting.
- Company also not in compliance with minimum stockholders' equity of $2.5M; extension to Feb 15, 2023.
- Company intends to effect 1-for-40 reverse stock split (previously approved) and take other measures to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029125/000143774923000652/0001437749-23-000652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029125/000143774923000652/pbla20230106_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-000652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer